Aberdeen Group plc

Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,785,241	1,785,241	+430,421	+32%	$1.00	Q4 2025
30 Sep 2025	0%	+0%	$2,465,772	1,354,820	+463,372	+52%	$1.82	Q3 2025
30 Jun 2025	0%	0%	$1,292,600	891,448	0		$1.45	Q2 2025
31 Mar 2025	0%	+0%	$1,230,198	891,448	+7,744		$1.38	Q1 2025
31 Dec 2024	0.01%	+0%	$2,686,460	883,704	+512,049	+138%	$3.04	Q4 2024
30 Sep 2024	0%	+0%	$1,850,842	371,655	+79,511	+27%	$4.98	Q3 2024
30 Jun 2024	0%	+0%	$1,709,042	292,144	+92,144	+46%	$5.85	Q2 2024
31 Mar 2024	0%	0%	$1,588,000	200,000	0		$7.94	Q1 2024
31 Dec 2023	0%	+0%	$1,166,000	200,000	+200,000	NEW	$5.83	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.